These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 21576203

  • 1. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
    Ezzat M, El-Gammasy T, Shaheen K, Shokr E.
    Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
    [Abstract] [Full Text] [Related]

  • 2. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE).
    Schiffer L, Kümpers P, Davalos-Misslitz AM, Haubitz M, Haller H, Anders HJ, Witte T, Schiffer M.
    Nephrol Dial Transplant; 2009 Dec; 24(12):3708-12. PubMed ID: 19602475
    [Abstract] [Full Text] [Related]

  • 3. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
    Lee HT, Shiao YM, Wu TH, Chen WS, Hsu YH, Tsai SF, Tsai CY.
    J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
    [Abstract] [Full Text] [Related]

  • 4. Up regulation of serum tumor necrosis factor-related apoptosis inducing ligand in juvenile-onset systemic lupus erythematosus: relations with disease activity, antibodies to double -stranded DNA, nephritis and neutropenia.
    Ezzat MH, El-Gammasy TM, Shaheen KY, El-Mezdawi RA, Youssef MS.
    Int J Rheum Dis; 2013 Jun; 16(3):310-8. PubMed ID: 23981753
    [Abstract] [Full Text] [Related]

  • 5. Elevation of serum CXCL13 in SLE as well as in sepsis.
    Schiffer L, Kielstein JT, Haubitz M, Lührs H, Witte T, Haller H, Kümpers P, Schiffer M.
    Lupus; 2011 Apr; 20(5):507-11. PubMed ID: 21078761
    [Abstract] [Full Text] [Related]

  • 6. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
    Mak A, Cheung BM, Mok CC, Leung R, Lau CS.
    Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
    [Abstract] [Full Text] [Related]

  • 7. B-cell-attracting chemokine-1 (BCA-1/CXCL13) in systemic lupus erythematosus, its correlation to disease activity and renal involvement.
    Hafez SS, Saad Wel S, Shedid NH.
    Egypt J Immunol; 2014 Oct; 21(2):23-32. PubMed ID: 25812350
    [Abstract] [Full Text] [Related]

  • 8. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity.
    Wong CK, Wong PT, Tam LS, Li EK, Chen DP, Lam CW.
    J Clin Immunol; 2010 Jan; 30(1):45-52. PubMed ID: 19774453
    [Abstract] [Full Text] [Related]

  • 9. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Dolff S, Wilde B, Patschan S, Dürig J, Specker C, Philipp T, Kribben A, Witzke O.
    Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
    [Abstract] [Full Text] [Related]

  • 10. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V, Singh AP, Aggarwal A, Naik S, Misra R.
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [Abstract] [Full Text] [Related]

  • 11. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus.
    Kümpers P, David S, Haubitz M, Hellpap J, Horn R, Bröcker V, Schiffer M, Haller H, Witte T.
    Ann Rheum Dis; 2009 Oct; 68(10):1638-43. PubMed ID: 18930996
    [Abstract] [Full Text] [Related]

  • 12. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis.
    Hung WT, Chen YM, Lan JL, Chen HH, Chen YH, Chen DY, Hsieh CW, Wen MC.
    Lupus; 2011 Nov; 20(13):1404-10. PubMed ID: 21946514
    [Abstract] [Full Text] [Related]

  • 13. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
    Brunner HI, Gladman DD, Ibañez D, Urowitz MD, Silverman ED.
    Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
    [Abstract] [Full Text] [Related]

  • 14. Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis.
    Alzawawy A, Zohary M, Ablordiny M, Eldalie M.
    Int J Rheum Dis; 2009 Dec; 12(4):311-8. PubMed ID: 20374368
    [Abstract] [Full Text] [Related]

  • 15. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M.
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [Abstract] [Full Text] [Related]

  • 16. The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus.
    Kwan BC, Tam LS, Lai KB, Lai FM, Li EK, Wang G, Chow KM, Li PK, Szeto CC.
    Rheumatology (Oxford); 2009 Dec; 48(12):1491-7. PubMed ID: 19773408
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S, Nakano S, Watanabe T, Tamayama Y, Mitsuo A, Nakiri Y, Suzuki J, Nozawa K, Amano H, Tokano Y, Kobata T, Takasaki Y.
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [Abstract] [Full Text] [Related]

  • 19. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, Baba S, Hara M, Yamanaka H.
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [Abstract] [Full Text] [Related]

  • 20. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.